Completed
A Single Dose Study to Assess the Regional Absorption and Bioavailability of 100mg GSK2190915A
NCT01318980
- Conditions
- Asthma, Bronchial Diseases, Hypersensitivity, +6 more
- Locations
-
- GSK Investigational Site Nottingham, United Kingdom